Cannabinoid receptor 2 agonist promotes parameters implicated in mucosal healing in patients with inflammatory bowel disease

BACKGROUND: Cannabis benefits patients with inflammatory bowel disease (IBD). Cannabinoid receptors are expressed in gut immune cells and in epithelial cells of inflamed guts. Mucosal healing (MH) requires epithelial layer restoration. OBJECTIVE: To analyze the effects of CB2 agonist on parameters i...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:United European Gastroenterol J
Hlavní autoři: Tartakover Matalon, Shelly, Ringel, Yehuda, Konikoff, Fred, Drucker, Liat, Pery, Shaul, Naftali, Timna
Médium: Artigo
Jazyk:Inglês
Vydáno: SAGE Publications 2019
Témata:
Original Articles
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7184658/
https://ncbi.nlm.nih.gov/pubmed/32213014
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/2050640619889773
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky